Alembic Pharmaceuticals Stock Screener | Share Price & Fundamental Analysis
APLLTD
Pharmaceuticals
Share Price NSE
₹690.10
▲
34.15 (5.21%)
Share Price BSE
₹690.25
▲
34.10 (5.20%)
Track Alembic Pharmaceuticals share price live with TickJournal's free stock screener.
Analyze Alembic Pharmaceuticals share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Alembic Pharmaceuticals Market Cap
₹12,898.47 Cr.
APLLTD P/E Ratio (TTM)
21.24
Alembic Pharmaceuticals P/B Ratio
2.50
EPS (TTM)
₹29.68
Dividend Yield
1.63%
Debt to Equity
0.18
APLLTD 52 Week High
₹1039.10
Alembic Pharmaceuticals 52 Week Low
₹646.55
Operating Margin
15.00%
Profit Margin
8.80%
APLLTD Revenue (TTM)
₹1,784.00
EBITDA
₹286.00
Net Income
₹157.00
Total Assets
₹7,773.00
Total Equity
₹5,190.00
Alembic Pharmaceuticals Share Price History - Stock Screener Chart
Screen APLLTD historical share price movements with interactive charts. Analyze price trends and patterns.
Alembic Pharmaceuticals Company Profile - Fundamental Screener
Screen Alembic Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for APLLTD shares.
Alembic Pharmaceuticals is an India-based company that manufactures and markets generic pharmaceutical products globally. It operates in India Formulations, International Generics, and Active Pharmaceutical Ingredients (API) segments. The company has state-of-the-art research and manufacturing facilities approved by regulatory authorities, including the US FDA. Alembic produces a range of generics across...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
Chirayu R Amin
ISIN
INE901L01018
Alembic Pharmaceuticals Balance Sheet Screener
Screen APLLTD balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 7,773 | 6,446 | 6,183 | 7,122 | 6,709 | 5,989 | 4,778 | 3,941 | 2,689 | 2,429 |
| Current Assets | 4,088 | 3,079 | 2,910 | 2,861 | 2,652 | 2,463 | 1,958 | 1,825 | 1,373 | 1,511 |
| Fixed Assets | 2,524 | 2,547 | 2,398 | 1,798 | 1,788 | 1,552 | 1,159 | 993 | 799 | 708 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 171 | 172 | 175 | 168 | 361 | 1,047 | 570 | 576 | 94 | 84 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 5,190 | 4,818 | 4,371 | 5,238 | 5,067 | 3,190 | 2,718 | 2,220 | 1,902 | 1,597 |
| Share Capital | 39 | 39 | 39 | 39 | 39 | 38 | 38 | 38 | 38 | 38 |
| Reserves & Surplus | 5,152 | 4,779 | 4,331 | 5,198 | 5,028 | 3,182 | 2,681 | 2,182 | 1,865 | 1,560 |
Alembic Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen Alembic Pharmaceuticals income statement and profit fundamentals.
Analyze APLLTD quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Alembic Pharmaceuticals share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,784 | 1,717 | 1,919 | 1,892 | 1,521 | 1,564 | 1,678 | 1,703 | 1,407 | 1,498 | 1,605 | 1,634 | 1,426 | 1,263 | 1,475 |
| Expenses | 1,498 | 1,430 | 1,595 | 1,627 | 1,257 | 1,325 | 1,409 | 1,433 | 1,203 | 1,288 | 1,387 | 1,364 | 1,268 | 1,255 | 1,244 |
| EBITDA | 286 | 287 | 324 | 265 | 263 | 239 | 270 | 270 | 205 | 210 | 218 | 269 | 158 | 9 | 231 |
| Operating Profit % | 15.00% | 16.00% | 17.00% | 13.00% | 17.00% | 15.00% | 15.00% | 15.00% | 14.00% | 13.00% | 13.00% | 16.00% | 10.00% | 1.00% | 16.00% |
| Depreciation | 69 | 74 | 76 | 80 | 70 | 69 | 71 | 70 | 74 | 66 | 68 | 69 | 123 | 67 | 68 |
| Interest | 25 | 24 | 24 | 23 | 11 | 13 | 19 | 22 | 14 | 14 | 16 | 15 | 7 | 9 | 12 |
| Profit Before Tax | 192 | 190 | 224 | 162 | 183 | 157 | 180 | 178 | 116 | 130 | 135 | 185 | 29 | -67 | 151 |
| Tax | 35 | 37 | 40 | 30 | 5 | 23 | 27 | 40 | -36 | 9 | -2 | 4 | 7 | -2 | 18 |
| Net Profit | 157 | 154 | 184 | 132 | 178 | 135 | 153 | 138 | 153 | 121 | 137 | 180 | 22 | -66 | 133 |
| EPS | 7.98 | 7.85 | 9.40 | 6.76 | 9.07 | 6.84 | 7.79 | 7.01 | 7.76 | 6.14 | 6.95 | 9.23 | 1.11 | -3.35 | 6.78 |
Alembic Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen APLLTD cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 88 | 803 | 724 | 552 | 1,463 | 449 | 812 | 312 | 329 | 948 |
| Investing Activities | -568 | -321 | -448 | -372 | -840 | -731 | -756 | -884 | -486 | -307 |
| Financing Activities | 444 | -438 | -262 | -217 | -597 | 155 | 59 | 503 | -129 | -224 |
| Net Cash Flow | -37 | 45 | 14 | -37 | 26 | -127 | 115 | -69 | -286 | 417 |
Alembic Pharmaceuticals Shareholding Pattern Screener
See Alembic Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check Alembic Pharmaceuticals promoter holding and ownership changes for APLLTD on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 69.67% | 69.67% | 69.74% | 69.74% | 69.61% | 69.61% | 69.61% | 69.61% |
| FII Holding | 3.94% | 3.96% | 4.05% | 4.24% | 4.46% | 4.32% | 3.94% | 4.17% |
| DII Holding | 16.43% | 16.46% | 16.30% | 16.17% | 15.38% | 15.47% | 16.05% | 16.06% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 7.07% | 7.01% | 6.93% | 6.87% | 7.41% | 7.48% | 7.36% | 7.26% |
| Other Holding | 2.88% | 2.89% | 2.99% | 2.98% | 3.14% | 3.13% | 3.04% | 2.90% |
| Shareholder Count | 91,336 | 89,013 | 89,969 | 87,000 | 76,567 | 74,829 | 91,429 | 93,944 |
Alembic Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check Alembic Pharmaceuticals dividend history with payout and yield data.
View Alembic Pharmaceuticals dividend details including ex-dates and amounts for APLLTD stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹11.00 | 1.66% |
| 2024-March | ₹11.00 | 1.18% |
| 2023-March | ₹8.00 | 0.81% |
| 2022-March | ₹10.00 | 2.13% |
| 2021-March | ₹14.00 | 1.89% |
| 2020-March | ₹10.00 | 1.04% |
| 2019-March | ₹5.50 | 1.03% |
| 2018-March | ₹4.00 | 0.74% |
| 2017-March | ₹4.00 | 0.73% |
Alembic Pharmaceuticals Stock Index Membership
See which indices include Alembic Pharmaceuticals stock.
Check APLLTD index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
NIFTY 500
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY SMALLCAP250 MOMENTUM QUALITY 100
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
NIFTY500 SHARIAH
Alembic Pharmaceuticals Market Events Screener - Corporate Actions
Get Alembic Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check Alembic Pharmaceuticals stock events that may affect APLLTD share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-02-05 | 2026-02-05 | Quarterly Result Announcement | NA | 3.71% |
| 2025-11-04 | 2025-11-04 | Quarterly Result Announcement | NA | -0.92% |
| 2025-08-05 | 2025-08-05 | Annual General Meeting | NA | -1.57% |
| 2025-08-05 | 2025-08-05 | Quarterly Result Announcement | NA | -6.22% |
| 2025-07-29 | 2025-07-29 | Dividend | ₹ 11.00 /share | 10.49% |
| 2025-05-06 | 2025-05-06 | Quarterly Result Announcement | NA | 6.54% |
| 2025-02-03 | 2025-02-03 | Quarterly Result Announcement | NA | -9.02% |
| 2024-11-07 | 2024-11-07 | Quarterly Result Announcement | NA | -3.68% |
| 2024-07-22 | 2024-07-22 | Annual General Meeting | NA | 27.73% |
| 2024-07-15 | 2024-07-15 | Dividend | ₹ 11.00 /share | -1.72% |
| 2023-07-28 | 2023-07-28 | Dividend | ₹ 8.00 /share | 30.61% |
| 2022-08-17 | 2022-08-18 | Dividend | ₹ 10.00 /share | -16.05% |
| 2021-07-19 | 2021-07-21 | Dividend | ₹ 14.00 /share | -4.47% |
Alembic Pharmaceuticals Competitors Screener - Peer Comparison
Screen APLLTD competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 406,351 | 37.86 | 54,729 | 9.71% | 10,980 | 37.98 |
| Divis Laboratories | 155,472 | 63.26 | 9,712 | 18.67% | 2,191 | 33.24 |
| Torrent Pharmaceuticals | 134,945 | 61.20 | 11,539 | 6.99% | 1,911 | 32.75 |
| Lupin | 103,954 | 22.26 | 22,910 | 13.74% | 3,306 | 47.35 |
| Dr Reddys Laboratories | 101,601 | 18.27 | 33,741 | 16.73% | 5,725 | 39.36 |
| Cipla | 96,320 | 21.31 | 28,410 | 7.12% | 5,291 | 26.86 |
| Zydus Life Science | 86,964 | 17.29 | 23,511 | 18.55% | 4,615 | 41.42 |
| Mankind Pharma | 82,499 | 45.81 | 12,744 | 20.90% | 2,007 | 41.40 |
| Aurobindo Pharma | 77,462 | 22.37 | 32,346 | 9.43% | 3,484 | 64.38 |
| Alkem Laboratories | 62,867 | 25.87 | 13,458 | 3.70% | 2,216 | 42.54 |
Alembic Pharmaceuticals Company Announcements - News Screener
Screen APLLTD latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-05 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-04-05 | Announcement under Regulation 30 (LODR)-Cessation | - |
| 2026-04-05 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-04-04 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-04-04 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-04-04 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | - |
| 2026-04-04 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-03-30 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-03-30 | Closure of Trading Window | - |
| 2026-03-20 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-03-09 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Incorporation Of Subsidiary | - |
| 2026-03-06 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-03-06 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-03-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-03-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-27 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-02-26 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-24 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-18 | Completion Of United States Food And Drug Administration Inspection At Alembic Pharmaceuticals LimitedS Injectable Facility (F-3) At Karakhadi | - |
| 2026-02-11 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |